Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Biotron ( (AU:BIT) ) has provided an update.
Biotron has announced a change in the address of its share registry office, which is now located at Level 4, 44 Martin Place, Sydney. This move is effective from June 10, 2025, and all relevant documentation should be lodged at the new address. The change reflects an operational update for the company, ensuring stakeholders are informed of the new location for share registry activities.
More about Biotron
Biotron is a company operating in the biotechnology industry, focusing on the development of antiviral drugs and therapies. The company is dedicated to creating innovative solutions to combat viral infections, with a market focus on addressing unmet medical needs in this domain.
YTD Price Performance: -38.89%
Technical Sentiment Signal: Sell
Current Market Cap: A$2.65M
For detailed information about BIT stock, go to TipRanks’ Stock Analysis page.